First Allied Advisory Services’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-10,000
Closed -$1K 1192
2016
Q3
$1K Hold
10,000
﹤0.01% 1033
2016
Q2
$4K Hold
10,000
﹤0.01% 1034
2016
Q1
$4K Hold
10,000
﹤0.01% 1000
2015
Q4
$4K Buy
+10,000
New +$4.74K ﹤0.01% 1092

Other funds holding PVCT

First Allied Advisory Services's PVCT Position: Q4 2016 in Review

First Allied Advisory Services sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 10,000 shares — an estimated $1K sold.

First Allied Advisory Services first reported a position in PVCT in Q4 2015 and held it in 4 quarters. The position peaked at $4K in Q2 2016. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

  • First Allied Advisory Services reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
  • First Allied Advisory Services sold 10,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $1K.
  • First Allied Advisory Services first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2015 and held it in 4 quarters.
  • First Allied Advisory Services's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $4K in Q2 2016.
  • 8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on First Allied Advisory Services's 13F filing for Q4 2016, filed 13 Feb 2017.